Background Burkholderia latens was first recognised as a novel species of the Burkholderia cepacia complex (Bcc) in 2008. To date, there are no reports of pulmonary infection. Here, we report a cluster of three CF patients all with chronic infection by B latens, and all geographically linked.
Patient details Three patients have been identified as chronically infected with B latens: a 23-year female (FEV1 23% predicted), a 23-year M (FEV1 55%), and a 26-year female (FEV1 37%). The first two live within 1 mile of each other, and had been known to be infected with Bcc since childhood, though the organism was only finally identified as B latens in 2009. The third patient has been infected since May 2008, but had lived in the same town as the other patients until 2 years previously, and had attended the same paediatric centre.
Microbiology All B latens isolates were confirmed by recA sequencing at the national reference laboratory (Colindale), and PFGE profiles showed >90% similarity. Multiple isolates have been obtained from each of the three patients, and they are all considered chronically infected. Formal eradication has not been attempted.
Clinical impact Over the preceding 3 years, annual decline in FEV1 was 6.5% and 4.5% for the first two patients, though this deterioration was not attributed to Bcc. Annual decline in FEV1 for patient 3 was 1.5%, with no significant change in spirometry, rate of decline in spirometry or weight following isolation of B latens. There have been no cases of cepacia syndrome sepsis secondary to B latens.
Summary This is the first report of chronic pulmonary infection by B latens. All three subjects are geographically linked to the same town. The organism may come from a common environmental source, but cross infection cannot be ruled out. In this small sample there do not appear to have been any short-term unexpected adverse effects on lung health (patient 3), but it is not yet possible to infer the longer term effects of chronic B latens infection.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.